NCT04317352 (ERPANDIS-MRV) is a clinical trial of MVR in Pancreatic Neoplasms, sponsored by Universidad de Extremadura.

Who is sponsoring NCT04317352?

NCT04317352 is sponsored by Universidad de Extremadura.

What drugs are being tested in NCT04317352?

Interventions in NCT04317352: MVR.

What condition does NCT04317352 study?

NCT04317352 studies Pancreatic Neoplasms, Surgical Procedure, Unspecified.

Is NCT04317352 still recruiting?

NCT04317352 is currently completed. Last updated 23 March 2020.

Last reviewed 2020-03-23 · How we verify

NCT04317352: ERPANDIS-MRV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multivisceral Resection in Distal Pancreatectomy

Completed Last updated 23 March 2020

What this trial tests

trial testing MVR in Pancreatic Neoplasms in 435 participants. Completed in 1 March 2020.

Timeline

1 March 2019

Primary endpoint
31 December 2019

1 March 2020

Quick facts

Lead sponsor	Universidad de Extremadura
Status	Completed
Study type	OBSERVATIONAL
Enrollment	435
Start date	1 March 2019
Primary completion	31 December 2019
Estimated completion	1 March 2020
Sites	1 location across Spain

Drugs / interventions tested

Conditions studied

Pancreatic Neoplasms — all drugs for Pancreatic Neoplasms →
Surgical Procedure, Unspecified — all drugs for Surgical Procedure, Unspecified →

Sponsor

Universidad de Extremadura

Who can join

18 and older, any sex, with Pancreatic Neoplasms or Surgical Procedure, Unspecified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to evaluate the characteristics of the patients and the results of morbidity and mortality after distal pancreatectomy isolated or accompanied by multivisceral resection including cholecystectomy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Distal pancreatectomy with multivisceral resection: A retrospective multicenter study - Case series.
Ramia JM, Del Río-Martín JV, Blanco-Fernández G, Cantalejo-Díaz M, et al · · 2020 · cited 10× · PMID 32860956 · DOI 10.1016/j.ijsu.2020.08.024

Verify or expand the search:

Other recruiting trials for Pancreatic Neoplasms

Currently open trials in the same condition.

NCT07504471 — Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhib · Phase 2 · recruiting
NCT07139236 — Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD · recruiting
NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
NCT06939023 — Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) · NA · recruiting
NCT06953193 — Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia · NA · recruiting

Other Universidad de Extremadura trials

Trials by the same sponsor.

NCT07322822 — Active Coping Program for Chronic Musculoskeletal Pain: A Controlled Clinical Study · NA · not yet recruiting
NCT07361419 — Metabolic Response to Supine Physiotherapy in Mechanically Ventilated ICU Patients · active not recruiting
NCT07084337 — Effects of a Bodypump Training Program on Resting Blood Pressure and Physical Fitness in Sedentary Older Adults With Hyp · NA · completed
NCT07276412 — Study on the Effect of a Gamified Health Education Programme on Primary School Children · NA · recruiting
NCT06346249 — Workplace Based Physiotherapy of Elderly-care Workers With Non-specific Neck Pain. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04317352 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Extremadura
Last refreshed: 23 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04317352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing